Guidance is needed to mitigate the consequences of analytic errors during antimicrobial susceptibility testing for TB

Int J Tuberc Lung Dis. 2021 Oct 1;25(10):791-794. doi: 10.5588/ijtld.21.0428.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antitubercular Agents* / pharmacology
  • Humans
  • Microbial Sensitivity Tests
  • Mycobacterium tuberculosis* / drug effects
  • Tuberculosis* / drug therapy
  • Tuberculosis* / microbiology

Substances

  • Antitubercular Agents